Form 4: Celularity CEO Robert Hariri Reports Stock Transactions Following RSU Vesting
SEC Form 4
Celularity Inc. CEO Robert J. Hariri reports the vesting of restricted stock units (RSUs) and subsequent stock transactions.
Summary
- On April 13, 2025, Celularity Inc. CEO Robert J. Hariri vested 3,281 restricted stock units (RSUs) which converted into Class A Common Stock.
- Hariri also disposed of 1,154 shares of Class A Common Stock to cover tax withholding obligations related to the RSU vesting at a price of $1.64 per share.
- Following these transactions, Hariri directly owns 20,328 shares of Class A Common Stock and 3,281 RSUs.
Sentiment
Score: 5
Explanation: This is a routine disclosure of stock transactions related to executive compensation. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This is a standard SEC Form 4 filing, reflecting changes in beneficial ownership by a company insider. Such filings are common and provide transparency to the market regarding insider transactions.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect routine executive compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| 04/13/2022 | Reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2025. |
| 04/13/2025 | Vesting date of 3,281 RSUs and subsequent conversion to Class A Common Stock. |
| 04/15/2025 | Date of Form 4 signature. |
Keywords
Celularity Inc, Robert J. Hariri, RSU, Class A Common Stock, Vesting, Form 4, SEC
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.